Crown Laboratories, a portfolio company of Hildred Capital Partners, has acquired US-based medical aesthetics firm Bellus Medical for an undisclosed sum.
Image: Crown Laboratories has acquired medical aesthetics firm Bellus Medical. Photo: courtesy of adamr / FreeDigitalPhotos.net.
Based in Addison of Texas, US, Bellus Medical is engaged in the development and supply of a range of medical aesthetics products to its customers.
Bellus Medical, which will be included in the Crown’s new aesthetics division, will be renamed as Bellus Aesthetics.
The company’s products and devices include SkinPen, Skinfuse and Allumera, as well as ProGenTM / RegenLab.
Bellus Medical CEO Joe Proctor said: “The Crown Labs organization is culturally compatible and brings us the additional resources we need to expand our infrastructure, support future growth, and better serve our valued network of providers.”
SkinPen is an advanced microneedling device, which secured approval from the US Food and Drug Administration (FDA).
SkinPen is claimed to be the only FDA-approved medical grade microneedling device used exclusively by healthcare professionals to enhance the appearance of facial acne scars.
Skinfuse is a post-microneedling protocol, while Allumera is a light-activated cream and ProGenTM / RegenLab includes platelet-rich plasma systems.
Skinfuse enables to offer right ingredients at the right time for the right procedure and helps to deliver essential nutrients into skin cells to optimize the results of microneedling for 90 days and more.
Lowenstein Sandler served as legal advisor to Crown Laboratories and Hildred, while Piper Jaffray and Perkins Coie acted as financial and legal advisors to Bellus Medical.
Crown Laboratories president and CEO Jeff Bedard said: “Bellus has assembled a truly impressive team with an enviable track record of innovation in aesthetics, exemplified by the SkinPen, the first ever FDA-cleared microneedling device for acne scarring.
“We believe there is a tremendous opportunity for us in aesthetics, and with Bellus as the cornerstone of our new division, we expect to expand our portfolio meaningfully in the years ahead.”
Crown Laboratories is a specialty pharmaceutical firm which supplies a range of pharmaceutical and consumer products.
The firm produces Blue Lizard Australian sunscreen products, Vita Liberata organic sunless tanning and skincare products, and various dermatological products. Its prescription portfolio is comprised of branded products such as AlaScalp, AlaQuin and Tri-Derm.